ANGEPASSTE DOSIS EINES KONTRASTMITTELS

Patent europeic · EP3728046 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3728046
Numer da la dumonda
EP18822374
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-12-2018
Publitgà
28-10-2020
Concedì
14-08-2024
Stritgà
23-07-2025
Motiv
Taxa annuala betg pajada
Classas IPC
B65B 3/00 (2006.01)
A61M 5/00 (2006.01)
A61M 5/142 (2006.01)
A61M 5/168 (2006.01)
A61M 5/172 (2006.01)
B65B 1/30 (2006.01)
B65B 3/26 (2006.01)
B65B 31/00 (2006.01)
B65B 59/00 (2006.01)
B65B 59/02 (2006.01)
Prioritad
GB 201721463 20.12.2017
Dumonda PCT
PCT/EP2018/086359 20.12.2018
Publicaziun PCT
WO2019/122223 27.06.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2025

  2. 25-06-2025

    Midada

    Published in Swissreg on 25.06.2025

  3. 14-08-2024

    Concedì

    Published in Swissreg on 14.08.2024

Partidas

Possessur

GE Healthcare AS

Nydalen, Nycoveien 1 P.O. Box 4220, 0485 Oslo, NO

Inventur

WYNN, Duncan

St Giles, Buckinghamshire HP8 4SP, GB

LANGSETH-MANRIQUE, Karina

0485 Oslo, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.